Chelsea Counsel Company’s Celgene Corp CELG Stock Holding History

Chelsea Counsel Company’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,000	Closed	-$232K	–	89
2016 Q4	$232K	Sell	2,000 -500	-20%	-$55.7K	0.12%	81
2016 Q3	$261K	Buy	+2,500	New	+$271K	0.13%	82
2016 Q2	–	Sell	-2,000	Closed	-$200K	–	128
2016 Q1	$200K	Hold	2,000	–	–	0.06%	122
2015 Q4	$240K	Sell	2,000 -2,400	-55%	-$278K	0.07%	128
2015 Q3	$476K	Buy	4,400 +100	+2%	+$12.4K	0.11%	88
2015 Q2	$498K	Sell	4,300 -300	-7%	-$34.3K	0.11%	90
2015 Q1	$530K	Sell	4,600 -200	-4%	-$23.9K	0.11%	81
2014 Q4	$537K	Buy	4,800 +1,100	+30%	+$116K	0.11%	79
2014 Q3	$351K	Buy	+3,700	New	+$334K	0.07%	96
2014 Q2	–	Sell	-9,600	Closed	-$670K	–	136
2014 Q1	$670K	Buy	9,600 +5,200	+118%	+$412K	0.14%	71
2013 Q4	$372K	Sell	4,400 -1,200	-21%	-$95K	0.09%	78
2013 Q3	$432K	Buy	5,600 +200	+4%	+$14K	0.09%	78
2013 Q2	$316K	Buy	+5,400	New	+$325K	0.08%	78

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Chelsea Counsel Company's CELG Position: Q1 2017 in Review

Chelsea Counsel Company sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 2,000 shares — an estimated $232K sold.

Chelsea Counsel Company first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $670K in Q1 2014. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Chelsea Counsel Company reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Chelsea Counsel Company sold 2,000 Celgene Corp shares in Q1 2017, an estimated $232K.
Chelsea Counsel Company first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
Chelsea Counsel Company's Celgene Corp position peaked at $670K in Q1 2014.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Chelsea Counsel Company's 13F filing for Q1 2017, filed 20 Apr 2017.